Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

651
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
651
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

2.1K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.1K
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

1.3K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.3K
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

1.1K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
1.1K
Oral Hypoglycemic Agents: Sulfonylureas01:17

Oral Hypoglycemic Agents: Sulfonylureas

1.7K
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
1.7K
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

344
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
344

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sentinel Lymph Node Biopsy Versus Elective Neck Dissection in Carcinoma of the Tongue and Floor of the Mouth.

Cancers·2025
Same author

Sensitive determination of lead in an herbal tea matrix utilizing carbon doped CuO nanoparticles as solid phase adsorbent.

Food chemistry·2025
Same author

PET/MR for predicting extranodal extension of head and neck cancer.

Neuroradiology·2025
Same author

Staging and Treatment Implications in Small Oral Squamous Cell Carcinoma with Bone Infiltration.

Biomedicines·2025
Same author

Revised consensus guidelines for the use of cone-beam computed tomography/ digital volume tomography.

Swiss dental journal·2024
Same author

Recurrence Detection by Hybrid [ <sup>18</sup>F]FDG-PET in Advanced Head and Neck Squamous Cell Carcinoma.

Head & neck·2024
Same journal

Combination of gelatin sponge and tranexamic acid for hemostasis after tooth extraction in anticoagulated patients: a scoping review.

Swiss dental journal·2026
Same journal

Association of periodontitis severity and tooth loss with gastric cancer: a cross-sectional study.

Swiss dental journal·2026
Same journal

Intraductal salivary gland irrigation - a critical appraisal of an alternative treatment approach for patients with hyposalivation and xerostomia

Swiss dental journal·2026
Same journal

[Enamel pearl with severe consequences for the tooth and periodontium].

Swiss dental journal·2026
Same journal

[Lipoma on the Tongue].

Swiss dental journal·2026
Same journal

[Odontogenic Keratocyst in the Anterior Maxilla: A Case Report].

Swiss dental journal·2026
See all related articles

Related Experiment Video

Updated: Apr 7, 2026

A Microplate Assay to Assess Chemical Effects on RBL-2H3 Mast Cell Degranulation: Effects of Triclosan without Use of an Organic Solvent
17:35

A Microplate Assay to Assess Chemical Effects on RBL-2H3 Mast Cell Degranulation: Effects of Triclosan without Use of an Organic Solvent

Published on: November 1, 2013

40.7K

[Solcoseryl® – mechanism and risks].

Ayhan Yildirim1, Philipp Metzler, Martin Lanzer

  • 1Clinique et policlinique de chirurgie buccale et maxillo-faciale, Centre de médecine dentaire de l’Université de Zurich, Zurich, Switzerland.

Swiss Dental Journal
|July 17, 2015
PubMed
Summary
This summary is machine-generated.

Solcoseryl®, a protein-free hemodialysate from veal calves, enhances oxygen and glucose transport to hypoxic cells. It stimulates tissue repair and regeneration, aiding in conditions like oral inflammation.

Keywords:
Solcoseryl®Pâte adhésive bucco-dentaire

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.7K
Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
04:09

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices

Published on: June 13, 2025

1.7K

Related Experiment Videos

Last Updated: Apr 7, 2026

A Microplate Assay to Assess Chemical Effects on RBL-2H3 Mast Cell Degranulation: Effects of Triclosan without Use of an Organic Solvent
17:35

A Microplate Assay to Assess Chemical Effects on RBL-2H3 Mast Cell Degranulation: Effects of Triclosan without Use of an Organic Solvent

Published on: November 1, 2013

40.7K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.7K
Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
04:09

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices

Published on: June 13, 2025

1.7K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Tissue Regeneration

Context:

  • Hypoxic cellular conditions require therapeutic interventions to restore metabolic function.
  • Tissue damage necessitates agents that promote healing and cellular repair.
  • Solcoseryl® is a hemodialysate derived from cellular and serum components.

Purpose:

  • To elucidate the biochemical and physiological effects of Solcoseryl®.
  • To investigate Solcoseryl®'s role in improving cellular metabolism under hypoxia.
  • To assess Solcoseryl®'s efficacy in stimulating reparative and regenerative processes.

Summary:

  • Solcoseryl® is a protein-free hemodialysate composed of low molecular weight components from cellular mass and blood serum.
  • It enhances oxygen and glucose transport to hypoxic cells, boosting intracellular ATP synthesis, aerobic glycolysis, and oxidative phosphorylation.
  • The agent activates tissue repair by stimulating fibroblast proliferation and collagen vascular wall repair.

Impact:

  • Solcoseryl® demonstrates potential in managing conditions associated with hypoxia and impaired tissue repair.
  • Its formulations (infusion, injection, gel, ointment, dental paste) offer versatile therapeutic applications.
  • Clinical use may improve outcomes in inflammatory oral conditions and tissue regeneration.